Chapter 1-1. Anaerobic infections (General): Epidemiology of anaerobic infections

Journal of Infection and Chemotherapy

Volumn 17, Issue , 2011, Pages 4-12

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFMETAZOLE; CEFOTIAM; CLINDAMYCIN; ERYTHROMYCIN; FLOMOXEF; IMIPENEM; MEROPENEM; MINOCYCLINE; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANAEROBIC INFECTION; ARTICLE; BACTERIAL FLORA; BACTERIUM ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE ASPOROGENOUS ROD-SHAPED BACTERIA; GRAM POSITIVE COCCI; HUMAN; LABORATORY TEST; OBSERVATIONAL STUDY; ACTINOMYCES; ANAEROBE; ASPIRATION PNEUMONIA; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; BLOOD CULTURE; CLOSTRIDIUM; COMMUNITY ACQUIRED PNEUMONIA; FINEGOLDIA MAGNA; FOLLOW UP; FUSOBACTERIUM; GASTROINTESTINAL DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OTORRHEA; PEPTOSTREPTOCOCCUS; PERITONSILLAR ABSCESS; PLEURA EFFUSION; PORPHYROMONAS; PREVALENCE; PREVOTELLA; PREVOTELLA BIVIA; PRIMARY INFECTION; PROPIONIBACTERIUM ACNES; ANAEROBIC BACTERIUM; BACTERIAL INFECTION; CLASSIFICATION; DRUG EFFECT; GRAM NEGATIVE ANAEROBIC BACTERIA; GRAM POSITIVE BACTERIUM; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRACTICE GUIDELINE; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; GRAM-NEGATIVE ANAEROBIC BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 84959564035     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-010-0169-y     Document Type: Article

References (18)

1. Oguri T. Review of anaerobe testing method-Degree of each method's contribution to labor saving, economy and clinical usefulness: to which extent should isolation and identification of anaerobes be performed?. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2001, 31:22-29.
2. Shinagawa N., Mashita K., Manabe T., Takeyama H., Yura J., Mizuno A., et al. Anaerobic bacteria isolated from surgical infections and their susceptibilities. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2002, 32:94-102.
3. Fujisawa T. Study of anaerobic infection in Oto-rhino-laryngology. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2005, 35:53-59.
4. Tamaya T. Anaerobic infection-how infections are transmitted: in the field of obstetrics and gynecology. Clin Microbiol 1998, 25:573-579.
5. Takahashi M. Anaerobic infection-How infections are transmitted: In the field of internal medicine. Clinical Microbiology 1998, 25:555-563.
6. Engelkirk P.G., Engelkirk J.D., Dowell V.R. Principles and practice of clinical anaerobic bacteriology 1992, Star, Blmont.
7. Oguri T., Misawa S., Nakamura A., Igari J. Current status of blood culture-with special reference to the 41-year data at the Juntendo University Hospital. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2002, 32:2-13.
8. Hiramatsu K. Role of anaerobes on infectious disease. Aspects from the clinical laboratory findings. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2003, 33:25-33.
9. Adachi K., Kamijo H., Annaka M., et al. Clinical significance of anaerobes isolated from blood-Gram-positive bacteria. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 1999, 29:58-61.
10. Oguri T. Ideal way of anaerobe testing under the comprehensive medical care-optimum methods of anaerobe testing with cost and profitability taken into account. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2004, 34:39-47.
11. Shinzato T., Saito A., Kohno S., Matsushima T., Watanabe A., Ooizumi K., et al. Prospective multicenter study on the causative organisms of community-acquired pneumonia in Japan: Incidence of anaerobes. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2002, 32:90-93.
12. NCCLS: Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard-sixth edition. (M11-A6). P1-41, NCCLS, Wayne, Pennsylvania, 2004.
13. Nakamura A., Oguri T., Misawa S., Igari J. Incidence of isolation and antibiotic susceptibility of anaerobic gram positive organisms from clinical specimens. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2001, 31:41-47.
14. Misawa S., Oguri T., Igari J., et al. Isolation and antimicrobial susceptibility of Clostridium difficile from clinical specimens, and detection of species-specific gene and toxin A (enterotoxin) gene by the polymerase chain reaction. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 1996, 26:27-35.
15. Yamazoe K., Kato N., Kato H., Tanaka K., Katagiri Y., Watanabe K. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Antimicrob Agents Chemother 1999, 43:2808-2810.
16. Oguri T., Misawa S., Nakamura A., Igari J. In vitro susceptibility of Bacteroides fragilis group species from clinical materials: trend of imipenem-resistant strains. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2000, 30:50-55.
17. Oguri T., Misawa S., Nakamura A., Kondo S., Igari J. Sensitivity of anaerobes to drugs-with special reference to annual changes in the sensitivity of Bacteroides fragilis group. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2005, 35:88-95.
18. Hayakawa S., Hamagishi M., Kitahara K., Mukaibata K., Ikeda K., Sakuma Y., et al. Percentage of drug-resistant anaerobes detected at our hospital. Nihon Kenkiseikin Kansensho Kenkyukai Zasshi (J Jpn Assoc Anaerob Infect Res) 2005, 35:96-100.